Introduction
Pain,one of the basicc linicalsymptoms,a lways exists and consequentlythereisaworldwide need foreffective therapies.Thereforeanurgentaction fort he treatment of acuteand chronicpain acceptable tothe patients is required. Thisw ill beunderstood ass uccessfuland satisfactory treatmentof pain. Suchtreatments arep resented in avast numberof scientificworksw hichh ave recentlyappeared in the field of applied analgesicor fundamentalresearchintonociception [1] .Forexample, phencyclidine (1-(1-phenylcyclohexyl)piperidine,C AS 956-90-1,P CP, I ,S cheme 1) derivativesexhibiting analgesica ctivity arewell knownfort hispurpose [2] [3] [4] [5] [6] [7] [8] [9] .
Experimentalevidencesuggests thatglutamatereceptors arei nvolved in pain control and behaviormechanism. Behavioral,electrophysiologicaland biochemical dataindicatethatt he N-methyl-D-asparate( NMDA) subtypesof glutamatereceptors areessentialforthe developmentof phenomenaa ssociated withchronicpain [10] .Inthistreatment,PCP bindstothe NMDA receptor complexand blocksNMDA-mediated gating of the calciumconductancechannel [11] .The binding of PCP to the NMDA receptorr esults in blocking of the voltagesensitivep otassiumand sodiumchannels.Thiscauses increased calciume ntry intothe nervecell,resulting in increased releaseo fn eurotransmitters att he presynapticnervee nding. The potencyof PCP analoguesin blocking the potassiumchannel in vitro highlycorrelatesw iththeirbehavioralp otency in vivo [12] .
Furthermore,various animalm odelsof nociception areused tocharacterizethe specificpain conditionsin humanbeings.Forexample,tail immersion,tail flick and hotplatee xperiments evaluated analgesiceffects on acutecutaneous thermalpain and intraplantarinjectionsof formalin,zymosanand carrageenanarem odels of acuteand chronicc hemicalp ain. [13] .
Inthisr esearch,1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol (PD, II,S cheme 1),a nanalogueo fPCP withamethylg roupo nthe aromaticring ( o -position) and hydroxylg rouponthe piperidine ring ( m -position),
Abstract
Phencyclidine (1-(1-phenylcyclohexyl) piperidine,CAS 956-90-1,PCP, I)and its derivativeshaveshownmanyanalgesiceffects.Inthisresearch,anewderivativeof PCP (1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol,PD, II)wassynthesized and its analgesic(acuteand chronicpains)e ffects weree xamined on rats using tail immersion (asamodel of acutethermal pain) and formalin (asamodel of acute and chronicc hemicalp ain) tests and the results arecompared toPCP and control groups.
The results indicated thatII produces higheranalgesiceffects in the tail immersion test compared tothe PCP and control groups,withamarked and significantincreasei ntail immersion latency fort he doses1,5and 10mg/kg. The formalin test showed thatPD (II)i snoteffectivei nacutechemicalpain (phaseI, 0-5 min afterinjection) in all dosesbut chronicpain (initial-phaseII, 15 -40min afterinjection) iss ignificantlyattenuated byt hiscompound compared toPCP and saline (control) in dosesof 5and 10mg/kg.
Itisconcluded thatII iseffectivei n acutethermal( in all doses)and chronic (dosesof 5and 10mg/kg) pains; however, itisnoteffectivei nacutechemicalpain compared toPCP and control.
Keyw ords
n Acuteand chronicpain n Analgesics n CAS 956-90-1 n Formalin test n Phencyclidine,derivative n Tail immersion test wasprepared and its analgesiceffects weree xamined on rats using tail immersion (asamodel of acutethermalpain) and formalin (asamodel of acuteand chronic chemicalpain) tests.The results arecompared withPCP and control groups.Asindicated in our previous work on thisfamily [4, 6, 8, 9] , incorporation of amethyl grouponthe aromaticring of the molecule will generate pronounced effects on electron distribution and dipole moments becauseo fi ts high electron donating character [14] .Inaddition,incorporation of ahydroxylg roup on the piperidine ring of the molecule wasanticipated tohavepronounced effects on its hydrophilicproperties [3, 15] and increasesthe polarity and solubility activities of the drug.
2.Materialsand methods

Material
Cyclohexanone,piperidine,3-piperidinol,b romobenzene, magnesiumturnings,diethyle ther,2-bromotoluene werep urchased from MerckChemicalCo. (Darmstadt,Germany). Melting points (uncorrected) wered etermined using adigitalElectroThermalMelting Pointapparatus (model 9100, ElectrothermalEngineeringLtd.,E ssex,U K).
1 Ha nd 13 2.2Chemistry (Scheme 1-3)
1-(1-Phenylcyclohexyl)piperidine (PCP)I
Thiscompound wasprepared in 58 %yield from 1-piperidinocyclohexanecarbonitrile( 1 )and phenylm agnesiumbromide according toaknownp rocedure [16] .The hydrochloride salt of I (m. p. 233 -234°C)wasprepared using 2-propanol and HCland wasr ecrystallized from 2-propanol [16] . 
-Hydroxypiperidinocyclohexylcarbonitrile III
Tail immersion test
Acutethermalp ain ismodeled byt he tail immersion test [18 -20] .Twenty minutesafterani .p.i njection [21] of drugs(PCP and its analogue,1,5and 10mg/kg) orane quivalentv olume of saline (control),the mice(n=12in eachgroup) werehoused in ananimalrestrainer.Then,the terminal5cmo ftheirt ails weref irst submerged intoroom temperaturewater(22~24°C) tocheckthe aversion towaterand then immersed in 52°C water.The reaction time between immersing the tail and its removalfrom heated waterwasmeasured.Cut-off latencyin 15 s wasemployed toavoid damaging the tail [21, 22] .
2.3.2Formalin test
Formalin test wasintroduced byDubuisson and Dennis [23] .In thist est,formaldehyde solution (50 l l,2. 
3.Results
Chemistry
Phencyclidine (I) and 1-[1- [2-methylphenyl] [cyclohexyl]-3-piperidinol ( II) weresynthesized byreaction of substituted Grignardreagentand carbonitrile compounds.To obtain strongerhydrophilic, polarity and solubility properties,ahydroxylg roupwass ubstituted on the piperidine ring and amethylgroupwassubstituted on the aromaticring of the molecule whichg iveshigh electron donating property tothisgrouptoachievem oree lectron distribution and dipole moments.Aknownp rocedurewasapplied fort he synthesisof compounds I and III withthe appropriatem odifications [16, 17] . Spectroscopicdata(IR, 1 Ha nd 13 CN MR, mass)confirmed the structureo fthe compound II.The melting points of the knowncompoundsalsoconfirmed their identity.The purity of eachcompound waschecked by TLC using ethylacetate-hexane ast he eluent.
3.2Pharmacology 3.2.1 Generalconsideration
Mortality (numberof deaths),morbidity (defined asany abnormalcondition orbehaviorduetoadisorder),irritability (ac ondition of aggressiveness orincreased responseo nh andling) and otherr elated abnormalstates wereo bserved in experimentalanimals.However,the motorcoordination index(measured byr ota-rod apparatus,H arvard,U K)d id notindicateanys ignificantdifferencesbetween control and treated mice.
3.2.2Analgesica ctivity of PCP (I)and PD (II) hydrochloride withthe tail immersion test
Intraperitonealinjection of PCP, PD and saline (control) in three doses(1,5and 10mg/kg) generated analgesic effects in the tail immersion test.The results indicate thatPD canp roducestrongeranalgesiceffects on the tail immersion test (asamodel of acutethermalp ain) in comparison toPCP and control groups,withasignificantincreasei ntail immersion latencyin dosesof 1,5 and 10mg/kg (Fig. 1) . Thereforei ts eemst hats trong electron donating propertiesof the methylg roupo n para position of the phenylring and alsoh ydrophilic polarity and solubility propertiesof the hydroxylg roup on the piperidine ring facilitatebinding tothe NMDA receptorcomplexand could increasetail immersion latenciesin comparison withPCP and control groups,a s anticipated. The differencesin the tail immersion latencieswereevaluated using the analysisof variancemethod (ANOVA). fectivei nacutechemicalp ain in all dosesbut chronic pain could besignificantlyattenuated byt hiscompound compared toPCP and saline (control) groupsin dosesof 5and 10mg/kg ( Table 1 ). The differencesin the pain scoresw ereevaluated using ANOVA.
Discussion
PCP wasoriginallyintroduced asageneralanaesthetic agent.Becauseo fseverep sychomimeticside effects it wass ubsequentlyw ithdrawnf rom application in humans.However,the focus of recentr esearcho nPCP hasshifted its useasananestheticprescription drugtowardthe useasapotentialn europharmaceuticald rug [24] a nd the interest wasinitiated on working on its derivativesoranalogues [25] . The NMDA receptorisaligand gated ion channel whichservesasone of the primary substratesforexcitatory neurotransmission in the centraln ervous system (CNS). Excessiveo rabnormalNMDA receptoractivity hasbeen linked withn umerous neuropathologicalconditionsincluding acuten eurotoxicity whicho ccurs subsequenttoheadtraumaand ischemicstroke aswell asa numberof chronic, neurodegenerativedisorders including neuropathicpain [26] .
Inthisresearch,anewderivativeofPCP withdifferent substitutionsin its phenyland cyclohexane ringsw as synthesized. Becauseo fthe strongeranalgesiceffects of some of the synthesized derivativesof PCP bearing methyl,methoxy and hydroxylg roupson phenyland cyclohexane rings [2, 3, 7] , anewderivativeo fPCP with modifications/substitutionsin its phenyland cyclohexane ringswassynthesized and the analgesiceffects were studied using tail immersion and formalin tests.
Conclusion
Similart oo ur previous findingson the analgesiceffects of thisfamily,P D( II)could diminishthermal( all doses in the tail immersion test)but notchemical(all dosesin the formalin test)acutep ains.Chronicpain could also besignificantlyattenuated byt hisnewdrugi ncomparison withPCP and saline (control) in dosesof 5and 10mg/kg.
Itcanbealsoconcluded thatadding amethylg roup tothe aromaticring (withh igh electron donating property)resulted in higherelectron distribution and dipole moments of PCP.Moreover,adding ahydroxylgroupto the piperidine ring (withh ydrophilicproperty)i ncreased the polarity and solubility activity of thisnew drug( PD, II).
Therefore,suchm odificationson the PCP molecule areuseful,c ausing diminished thermaland chronic pain in tail immersion and formalin tests in mice. Heruntergeladen von: University of Liverpool. Urheberrechtlich geschützt.
